Jean-Michel Rondeau

6PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - amino acids and metabolitesAutoimmunityBiomaterialsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 20, 2025
Revealing Unpredicted Aspartic Acid Isomerization Hotspots by Probing Diagnostic Fragmentation Propensities in Top-Down and Middle-Down Mass Spectrometry.

Blandine Denefeld, Joanna Hajduk, Jure Cerar

|Dec 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold Morphing.

Juraj Velcicky, Estelle Ngo, Matthias R Bauer

|Sep 14, 2024
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors.

Juraj Velcicky, Matthias R Bauer, Achim Schlapbach

|Sep 29, 2023
"Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A".

Sharon Fischman, Itay Levin, Jean-Michel Rondeau

|Apr 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies.

Qing Sheng, Joseph A D'Alessio, Daniel L Menezes

Pageof 1